FIELD: medicine.
SUBSTANCE: before onset of treatment or in the process of treatment patient is administrated 2,3-dimercaptopropane sodium sulfonate in the dose 50-500 mg by subcutaneous or intramuscular route depending on the patient mass and the expression degree of hyperhomocysteinemia. Method provides normalization of blood level homocysteine due to its elimination from body as reduced homocysteine after its complete release from blood protein-bound form and with retention of these proteins in circulation. Invention can be used in treatment of patients with renal insufficiency with the enhanced blood content of homocysteine who have increased concentration of low- and mean-molecular metabolites due to disturbance in urine formation and when carrying out heme-dialysis or heme-filtration is required.
EFFECT: improved treatment method.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2004 |
|
RU2281090C2 |
| METHOD FOR TREATING THE CASES OF RENAL INSUFFICIENCY | 1998 |
|
RU2154499C2 |
| METHOD FOR PSYCHOLOGICAL REHABILITATION IN PATIENTS WITH CHRONIC RENAL DISEASE BEING UPON HEMODIALYSIS-BASED THERAPY | 2005 |
|
RU2301688C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH STAGE V CHRONIC KIDNEY DISEASE AT DIALYSIS STAGE | 2020 |
|
RU2753127C1 |
| METHOD OF PREDICTING EFFICIENCY OF PLANNED STANDARD THERAPY OF ACUTE NEPHRITIS | 2010 |
|
RU2421126C1 |
| SOLUTION FOR PERITONEAL DIALYSIS | 2014 |
|
RU2567043C1 |
| SCREENING DIAGNOSTIC TECHNIQUE FOR ARTERIOVENOUS FISTULA STENOSIS IN PATIENTS WITH END-STAGE CHRONIC RENAL DISEASE | 2012 |
|
RU2508544C1 |
| METHOD FOR PREVENTING INFECTIOUS COMPLICATIONS ASSOCIATED WITH THE PERITONEAL CATHETER INSTALLATION IN THE PATIENTS WITH CHRONIC C5 RENAL DISEASE ON PERITONEAL DIALYSIS | 2018 |
|
RU2690951C1 |
| METHOD OF TREATING CHRONIC RENAL INSUFFICIENCY | 2009 |
|
RU2406539C2 |
| METHOD FOR EVALUATING EFFECTIVE IRON TRANSPORT IN PATIENT WITH RENAL INSUFFICIENCY | 2010 |
|
RU2436096C1 |
